Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
Recruiting
N/A
Interventional Study
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
Head &Amp;Amp; Neck Squamous Cell Carcinoma
Larynx Squamous Cell Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 85 (estimated)
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM) · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Delays between surgery and the initiation of post-operative radiotherapy (S-PORT) in head and neck cancer (HNC) patients are prevalent and associated with worse oncologic outcomes. This pilot study evaluates whether a proactive, automated care coordination system (PRONTO-HN) can improve adherence to recommended S-PORT intervals of ≤42 days at the Centre hospitalier de l'Université de Montréal (CHU…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All adult patients (age 18 or older).
* Pathologically confirmed oral cavity or laryngeal squamous cell carcinoma.
* Diagnosed from July 2024 to September 2026.
* With planned primary intention surgical resection.
* With or without adjuvant therapy.
* Treated at the Centre Hos…
Contacts